Nomega-Propyl-L-arginine, neuronal nitric oxide synthase (nNOS) inhibitor

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The biological target referred to as pan NOS (Nitric Oxide Synthase) CYP2D6 CYP2C9 and Cytochrome P450 2C8 + 2C9 + 2C19 + 2C12 involves various enzymes critical for the metabolism of drugs and endogenous compounds. Cytochrome P450 enzymes including CYP2D6 and CYP2C9 are important for oxidative reactions in drug metabolism. Known by their alternate names cytochromes are widely expressed in the liver. NOS enzymes synthesize nitric oxide from l-arginine which affects various signaling pathways. The molecular mass varies significantly across the individual enzymes of this target complex.

Biological function summary

Enzymes such as CYP2D6 and CYP2C9 play a significant role in drug metabolism. These are not individually active and often form part of larger enzyme complexes in the liver. NOS enzymes such as endothelial NOS and neuronal NOS produce nitric oxide an important signaling molecule. This indicates the dual role of these proteins affecting both metabolic and signaling pathways with the production of nitric oxide being central to this process.

Pathways

These enzymes are critical components in metabolic and signaling pathways. Cytochrome P450 enzymes like CYP2D6 and CYP2C9 are central to drug metabolism and hydroxylation reactions. They are closely related to other enzymes like CYP3A4 which too participate in these pathways. NOS enzymes engage in signaling pathways through the production of nitric oxide which modulates the vascular response. They relate biologically to proteins involved in the signal transduction processes.

Variations and dysfunctions in enzymes like CYP2D6 are linked to conditions such as adverse drug reactions and drug efficacy issues. For example altered CYP2C9 activity is associated with the metabolism of anticoagulants affecting therapy outcomes. NOS enzymes have significance in inflammatory diseases and cardiovascular disorders like hypertension where nitric oxide production is altered. This alteration impacts proteins such as soluble guanylate cyclase contributing to disease symptoms.